Skip to Main Content

Paper Details

ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy.
Oncoimmunology
56
2017
Author NameAffiliation
Jaume BonetEcole Polytechnique Federale de Lausanne
  • 1 - 1

Datasets

Release 1.2